| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K52037352 |
| PharmacoGx | BRD-K52037352 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | POLD1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | SLC4A9 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | GRK4 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | POMGNT2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | HTN3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | GLS2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | TP53I11 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | GTF2E1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | C15orf65 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | YARS2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
